Zinc finger protein 180 induces an apoptotic phenotype by activating METTL14 transcriptional activity in colorectal cancer-Reference-Cited by-同舟云学术

Zinc finger protein 180 induces an apoptotic phenotype by activating METTL14 transcriptional activity in colorectal cancer

Published:2024-07-25 Issue:4 Volume:52 Page:
ISSN:1021-335X
Container-title:Oncology Reports
language:
Short-container-title:Oncol Rep

Author:

Xu Liang¹,Chen Xi-Jie²,Yan Qian²,Lei Xin-Tao¹,Liu Hai-Ling¹,Xu Jing-Ping¹,Shang Wei-Te¹,Huang Jing-Lin¹,Chen Zhi-Ting¹,Tan Xiao-Li¹,Lin Han-Jie¹,Fu Xin-Hui¹,Zheng Li-Sheng³,Lan Ping²,Huang Yan¹

Affiliation:

1. Department of Pathology, The Sixth Affiliated Hospital, Sun Yat‑sen University, Guangzhou, Guangdong 510655, P.R. China

2. Guangdong Provincial Key Laboratory of Colorectal and Pelvic Floor Diseases, Guangdong Institute of Gastroenterology, The Sixth Affiliated Hospital, Sun Yat‑sen University, Guangzhou, Guangdong 510655, P.R. China

3. Department of Pathology, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, Guangdong 510080, P.R. China

Publisher

Spandidos Publications

Reference56 articles.

1. Cancer Statistics, 2021;Siegel;CA Cancer J Clin,2021

2. Colorectal cancer statistics, 2023;Siegel;CA Cancer J Clin,2023

3. Prognostic role of KRAS and BRAF in stage II and III resected colon cancer: Results of the translational study on the PETACC-3, EORTC 40993, SAKK 60–00 trial;Roth;J Clin Oncol,2010

4. Modified XELIRI (capecitabine plus irinotecan) versus FOLFIRI (leucovorin, fluorouracil, and irinotecan), both either with or without bevacizumab, as second-line therapy for metastatic colorectal cancer (AXEPT): A multicentre, open-label, randomised, non-inferiority, phase 3 trial;Xu;Lancet Oncol,2018

5. Gastrointestinal cancers in China, the USA, and Europe;Xie;Gastroenterol Rep (Oxf),2021